Sibutramine-associated adverse effects: a practical guide for its safe use.
about
Adverse Psychiatric Effects Associated with Herbal Weight-Loss ProductsAssociation of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean SubjectsA retrospective review of California poison control system data of sibutramine exposures.Sibutramine-induced mania as the first manifestation of bipolar disorder.Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States.The role of psychobiological and neuroendocrine mechanisms in appetite regulation and obesity.Sibutramine on cardiovascular outcome.Influence of sibutramine in addition to diet and exercise on the relationship between weight loss and blood glucose changes.Sibutramine (reductil®)-induced cutaneous leukocytoclastic vasculitis: a case reportSynthesis and biological evaluation of tert-butyl-5-methylpyrimidin-piperazine derivatives as anti-obesity agents.Early response to sibutramine in patients not meeting current label criteria: preliminary analysis of SCOUT lead-in period.The effect of sibutramine on platelet morphology of Spraque-Dawley rats fed a high energy diet.Transient thyrotoxicosis from thyroiditis induced by sibutramine overdose: a case report.Rats on a high-energy diet showing no weight gain present with ultrastructural changes associated with liver fibrosis.The Effect of Sibutramine, a Serotonin-Norepinephrine Reuptake Inhibitor, on Platelets and Fibrin Networks of Male Sprague-Dawley Rats: A Descriptive StudyBody Weight Reduction Associated with the Sibutramine Treatment: Overall Results of the PRIMAVERA Primary Health Care Trial
P2860
Q26784276-03E003C7-D8C2-451F-A031-CE90A10540A6Q29308187-8CDACFBC-8C99-4E72-A03F-5222D403A72BQ33506501-CAFC012B-C7E9-4266-B144-5CB96FADB3C3Q34274278-CDE8B4FA-D59C-483A-99AF-FF590CB9AC69Q35648995-3EDE02E9-BA3B-4670-9535-BF5866B72DEBQ36547159-AD8AEC2A-8B12-401B-A8F5-11D501E60C29Q36783695-2DE88CBA-9FC4-4C10-BFE1-D708FB0682B0Q39118038-74C05D85-BBFF-4B3E-9FCA-C36D636A9642Q39577175-F3396CBE-63B2-429D-ACA5-F36E44872F22Q42835466-2D5C42EF-19EE-4D0A-A6C4-32CBEB370918Q43264779-08CA1CB8-AC16-4788-8C58-4A03992C54A1Q44446716-B2808A96-68DC-45F9-9698-7A4BE039559CQ44756668-7628EB6E-EA3C-46BD-9ECA-2A787886A730Q47235418-3967C717-D65A-431A-A1A3-9C18D215A039Q58068053-C71CD167-ABBC-40BD-833A-C35DE7C14625Q58791828-ADB68567-D8E5-44CB-B08B-6201BA727EC4
P2860
Sibutramine-associated adverse effects: a practical guide for its safe use.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Sibutramine-associated adverse effects: a practical guide for its safe use.
@ast
Sibutramine-associated adverse effects: a practical guide for its safe use.
@en
Sibutramine-associated adverse effects: a practical guide for its safe use.
@nl
type
label
Sibutramine-associated adverse effects: a practical guide for its safe use.
@ast
Sibutramine-associated adverse effects: a practical guide for its safe use.
@en
Sibutramine-associated adverse effects: a practical guide for its safe use.
@nl
prefLabel
Sibutramine-associated adverse effects: a practical guide for its safe use.
@ast
Sibutramine-associated adverse effects: a practical guide for its safe use.
@en
Sibutramine-associated adverse effects: a practical guide for its safe use.
@nl
P2093
P2860
P1433
P1476
Sibutramine-associated adverse effects: a practical guide for its safe use.
@en
P2093
Florentin M
Liberopoulos EN
P2860
P304
P356
10.1111/J.1467-789X.2007.00425.X
P577
2007-11-23T00:00:00Z